News: AbbVie Inc (ABBV.K)

ABBV.K on New York Consolidated

55.20USD
22 Aug 2014
Price Change (% chg)

$0.24 (+0.44%)
Prev Close
$54.96
Open
$54.87
Day's High
$55.27
Day's Low
$54.36
Volume
9,314,643
Avg. Vol
10,064,283
52-wk High
$58.27
52-wk Low
$42.26

Search Stocks
Select another date:

Tue, Aug 5 2014

Drug company won't appeal gay rights ruling to top U.S. court

SAN FRANCISCO, Aug 5 - AbbVie Inc will not seek U.S. Supreme Court review of a ruling in a lawsuit brought against the company that extended landmark constitutional protections for gays and lesbians, a company spokesman said on Tuesday.

AbbVie profit beats estimates on surging Humira sales

- AbbVie Inc, which last week announced plans to buy Dublin-based drugmaker Shire Plc for $55 billion, reported stronger-than-expected quarterly earnings on surging sales of its Humira treatment for rheumatoid arthritis.

UPDATE 3-AbbVie profit beats estimates on surging Humira sales

July 25 - AbbVie Inc, which last week announced plans to buy Dublin-based drugmaker Shire Plc for $55 billion, reported stronger-than-expected quarterly earnings on surging sales of its Humira treatment for rheumatoid arthritis.

U.S. drugmaker AbbVie finally wins Dublin's Shire with $55 billion deal

LONDON - U.S. drugmaker AbbVie Inc bought Dublin-based Shire Plc on Friday in a 32 billion pound ($54.7 billion) deal that will allow it to slash its tax bill by relocating to Britain. | Video

Shire and ITV lead late rally for UK's FTSE

LONDON, July 18 - Drugmaker Shire and TV group ITV nudged up Britain's stock market, enabling it to recover from earlier losses caused by concerns about Ukraine, after an airliner was shot down in the violence-ridden region.

AbbVie’s Shire merger backed with 13.5 billion pound bridge loan

LONDON - U.S. drugmaker AbbVie’s 32 billion pounds acquisition of Dublin-based Shire Plc is backed with a 13.5 billion pounds ($23.03 billion) bridge loan, according to the company's filing with the Securities and Exchange Commission in the US.

RLPC-AbbVie's Shire merger backed with 13.5 bln stg bridge loan

LONDON, July 18 - U.S. drugmaker AbbVie's 32 billion pounds acquisition of Dublin-based Shire Plc is backed with a 13.5 billion pounds ($23.03 billion) bridge loan, according to the company's filing with the Securities and Exchange Commission in the US.

Shire rally props up UK's FTSE

LONDON, July 18 - A rise in drug maker Shire propped up Britain's stock market on Friday, cushioning it to an extent from concerns about the conflict in Ukraine, where a passenger plane was shot down over the rebel-controlled east.

AbbVie CEO says tax is not primary reason for buying Shire

LONDON - Pharmaceutical firm AbbVie's chairman and chief executive said tax benefits were not the main reason it bought London-listed Shire .

Select another date:
Search Stocks